[
    "{\"step_by_step_thinking\": \"According to the relevant documents, omaveloxolone is described as an activator of NFkB. Document [0] states that omaveloxolone activates the antioxidative transcription factor Nrf2 and inhibits the pro-inflammatory transcription factor NF-\u03baB. Document [1] mentions that omaveloxolone is an Nrf2 activator and NF-kB suppressor. Document [4] also refers to omaveloxolone as an Nrf2 activator. Therefore, based on the information provided in the documents, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]